Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | LRK-4189 |
| Trade Name | |
| Synonyms | LRK4189|LRK 4189 |
| Drug Descriptions |
LRK-4189 targets PIP4K2C for degradation, which may lead to tumor cell death and activation of anti-tumor immune response (Journal for ImmunoTherapy of Cancer. 2025;13:1281). |
| DrugClasses | |
| CAS Registry Number | 3063346-83-5 |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Fluorouracil + Irinotecan + Leucovorin + LRK-4189 | Fluorouracil Irinotecan LRK-4189 Leucovorin | 0 | 1 |
| Fluorouracil + Leucovorin + LRK-4189 + Oxaliplatin | Fluorouracil LRK-4189 Leucovorin Oxaliplatin | 0 | 1 |
| LRK-4189 | LRK-4189 | 0 | 1 |